FDA approved calcium channel blockers inhibit SARS CoV 2 infectivity in epithelial lung cells getmixapp
FDA approved calcium channel blockers inhibit SARS CoV 2 infectivity in epithelial lung cells getmixapp
Covid-19 has infected more than 14 million people worldwide causing over 600.000 deaths[1][1]. The disease is caused by the severe acute respiratory syndrome coronavirus (CoV) 2 (SARS-CoV-2), which shares a high sequence similarity to SARS CoV[2][2]. Currently there are no vaccinations available to provide protection and the only antiviral therapy in active use in patients is remdesivir, which...
You've added this content to your favorites.
Post your comment
Load More